Pulmonary Hypertension

ISBN-13: 9781588296610 / Angielski / Twarda / 2008 / 464 str.

Nicholas S. Hill; Harrison W. Farber

Opis

This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments over the past decade. The discoveries of endothelin overexpression as well as prostacyclin and nitric oxide deficiency in association with pulmonary hypertension have led to important therapeutic insights. The new therapies have led to significant improvements in patient function, quality of life and survival. In this book, expert authors describe these new therapies. It will be of interest not only to cardiologists, pulmonary specialists and rheumatologists, but also many nurses and pharmacotherapists.

Recenzje

From the reviews:

"This is a comprehensive review of pulmonary hypertension from pathophysiology to therapeutic options. ... This book provides current, comprehensive, and clinical relevant information from pathophysiology to a wide range of therapeutic options. The intended audience includes cardiologists and pulmonary specialists, intensivists, and rheumatologists, as well as those healthcare professionals who face this clinical situation in their everyday practice. ... This complete, up-to-date review of pulmonary hypertension covers all aspects of the disease from its pathophysiology to optimal therapeutic management." (Adriana Maria Rosario, Doody's Review Service, September, 2008)

"It is thus timely to release an up-dated textbook to the growing number of physicians who have an interest in pulmonary vascular medicine. Pulmonary Hypertension will undoubtedly provide useful information on the condition to readers. ... will be very helpful to the busy clinician who is treating patients with pulmonary hypertension. ... There is no doubt that this book will be of interest to nurses, medical trainees, and physicians from various fields who witness the burden of pulmonary hypertension in their practice." (Marc Humbert, The New England Journal of Medicine, November, 2008)

"For those who want a comprehensive, concise but not repetitive review of pulmonary hypertension with up to date review of therapy, this book is it. A well done review of the subject from history, diagnosis, genetics to chapters on the newest therapies. ... It reads well, can be read in one session for an overview or studied carefully for those interested in a thorough introduction to the field. ... A good additions to one's library covering a very specialized field." (John Somberg, American Journal of Therapeutics, June, 2010)

Spis treści

Chapter 1. Historical Perspective: A Century of Primary (Idiopathic) Pulmonary Hypertension. Alfred P. Fishman MD Chapter 2: Classification of Pulmonary Hypertension C. William Hargett, MD and Victor F. Tapson, MD (2 Tables) Chapter 3. Diagnostic Approach to Pulmonary Arterial Hypertension (1 figure) Ronald J. Oudiz, MD, FACP, FACC Chapter 4. Pathophysiology of Pulmonary Arterial Hypertension Harrison W. Farber, M.D. Chapter 5: Pulmonary Hypertension Genes (Check references) Elisabeth Donlevy Willers, MD and Ivan M. Robbins, MD Chapter 6. The Right Ventricle in Pulmonary Hypertension Andrew C. Stone, MD and James R. Klinger, MD Chapter 7. Congenital Heart Disease Associated Pulmonary Arterial Hypertension Michael J. Landzberg, MD Chapter 8. Connective Tissue Disease Associated Pulmonary Hypertension Kimberly Fisher, MD, Nicholas S. Hill, MD and Harrison Farber, MD Chapter 9. Pulmonary Hypertension associated with HIV, Liver Disease, Sarcoidosis and Sickle Cell Disease. Kimberly A. Fisher, MD and Elizabeth S. Klings, MD Chapter 10. Chronic Thromboembolic Pulmonary Hypertension Victor J. Test, MD, William R. Auger, MD and Peter F. Fedullo, MD. Chapter 11. General Therapeutic Approach and Traditional Therapies Nicholas S. Hill, MD and Elizabeth Klings, MD Chapter 12. Prostacyclin Therapy for Pulmonary Arterial Hypertension Nicholas S. Hill MD, Todd F. Vardas, MD and Vallerie McLaughlin MD Chapter 13. Endothelin and its blockade in pulmonary arterial hypertension David Langleben, MD, FRCPC Chapter 14. PDE 5 Inhibitors and the cGMP Pathway in Pulmonary Arterial Hypertension Ioana R. Preston MD Chapter 15. Statins for treatment of pulmonary hypertension John L. Faul MD, Peter N. Kao MD, Toshihiko Nishimura MD, Arthur Sung MD, Hong Hu MD and Ronald G. Pearl MD, PhD Chapter 16. Transitions and Combination Therapy for Pulmonary Arterial Hypertension Todd Hirschtritt MD, M. Kathryn Steiner MD and Nicholas S. Hill MD Chapter 17. Acute right ventricular dysfunction: focus on acute cor pulmonale Antoine Vieillard-Baron MD, François Jardin MD Chapter 18. Lung transplantion and atrial septostomy for pulmonary arterial hypertension E.P. Trulock MD Chapter 19 : New Directions in Pulmonary Hypertension Therapy Christopher M Carlin BSc (Hons) MB ChB (Hons) MRCP Andrew J Peacock MD FRCP

Blurb

This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments over the past decade. The discoveries of endothelin overexpression as well as prostacyclin and nitric oxide deficiency in association with pulmonary hypertension have led to important therapeutic insights. In addition, the identification of genes associated with pulmonary hypertension has just begun to open the door to new pathophysiologic insights. The new therapies have led to significant improvements in patient function, quality of life and survival.

This book will be of interest not only to cardiologists, pulmonary specialists and rheumatologists, but also many nurses and pharmacotherapists are becoming increasingly involved in the therapy of patients with pulmonary hypertension.